Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-CD82 Antibody (4K512) is a Rabbit antibody targeting CD82. Anti-CD82 Antibody (4K512) can be used in ELISA,ELISA(Cap).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μL | $92 | 7-10 days | |
100 μL | $268 | 7-10 days |
Description | Anti-CD82 Antibody (4K512) is a Rabbit antibody targeting CD82. Anti-CD82 Antibody (4K512) can be used in ELISA,ELISA(Cap). |
Alias | TSPAN27, ST6, SAR2, R2, KAI-1, KAI1, IA4, GR15, CD82 molecule, C33, 4F9 |
Ig Type | Monoclonal Rabbit IgG |
Clone | 4K512 |
Reactivity | Human |
Application | ELISA,ELISA(Cap) |
Recommended Dose | ELISA: 1:5000-1:10000; ELISA(Cap): 1:250-1:2000 |
Antibody Type | Monoclonal |
Host Species | Rabbit |
Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human CD82 / KAI-1 (rh CD82 / KAI-1; TMPY-02030; P27701-1; Gly 111-Leu 228). |
Purification | Protein A |
Appearance | Liquid |
Formulation | 0.2 μm filtered solution in PBS |
Research Background | CD82, also known as KAI-1, structurally belongs to tetraspanin family while categorised as metastasis suppressor gene on functional grounds. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signalling. Downregulation of CD82 expression is associated with the advanced stages of many human cancers and correlates with the acquisition of metastatic potential. Recent studies suggest that complex mechanisms underlie CD82 loss of function, including altered transcriptional regulation, splice variant production and post-translational protein modifications, and indicate a central role for CD82 in controlling metastasis as a 'molecular facilitator'. The loss of KAI1/CD82 expression in invasive and metastatic cancers is due to a complex, epigenetic mechanism that probably involves transcription factors such as NFkappaB, p53, and beta-catenin. A loss of KAI1 expression is also associated with the advanced stages of many human malignancies and results in the acquisition of invasive and metastatic capabilities by tumour cells. Thus, KAI1/CD82 is regarded as a wide-spectrum tumor metastasis suppressor. |
Conjucates | Unconjugated |
Immunogen | Recombinant Human CD82 / KAI-1 protein (TMPY-02030) |
Antigen Species | Human |
Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.